Antara Capital LP Inhibikase Therapeutics, Inc. Transaction History

Antara Capital LP

  • $17.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.63 - $1.44 $63,000 - $144,000
100,000 Added 33.0%
403,000 $299,000
Q3 2021

Nov 15, 2021
BUY
$1.79 - $2.81 $94,870 - $148,930
53,000 Added 21.2%
303,000 $576,000
Q2 2021

Aug 16, 2021
BUY
$2.8 - $6.23 $700,000 - $1.56 Million
250,000 New
250,000 $700,000

Others Institutions Holding IKT

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Inhibikase Therapeutics, Inc.

IKT Quotes by TradingView
  • Ticker IKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,227,100
  • Market Cap $50.5M
  • Description
  • Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...
More about IKT
Track This Portfolio

Track Antara Capital LP Portfolio

Follow Antara Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Antara Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email